Protein turnover occurs in all forms of life, with most proteins in the body constantly being synthesized and then degraded, permitting the removal of abnormal or unneeded proteins.
Humans turnover 1 - 2% of their total body protein, principally muscle protein, each day.
Approximately 75% of liberated amino acids are reutilized.
Urea diffuses from the liver, and is transported in the blood to the kidneys, where it is filtered and excreted in the urine.
A portion of the urea diffuses from the blood into the intestine, and is cleaved to CO2 and NH3 by bacterial urease.
This ammonia is partly lost in the feces, and is partly reabsorbed into the blood.
The rate of protein turnover varies widely for individual proteins, with short-lived proteins being rapidly degraded, having half-lives measured in minutes or hours, and long-lived proteins constituting the majority of proteins in the cell.
There are two major enzyme systems responsible for degrading damaged or unneeded proteins: the ATP-dependent ubiquitin-proteasome system of the cytosol, and the ATP-independent degradative enzyme system of the lysosomes.
Proteasomes degrade mainly endogenous proteins, that is, proteins that were synthesized within the cell.
Lysosomal enzymes degrade primarily extracellular proteins, such as plasma proteins that are taken into the cell by endocytosis, and cell-surface membrane proteins that are used in receptor-mediated endocytosis.
Proteins selected for degradation by the ubiquitin-proteasome system are first covalently attached to ubiquitin.
Ubiquitination of the target substrate occurs through linkage of the alpha carboxyl group of the C-terminal glycine of ubiquitin to the epilson amino group of a lysine on the protein substrate.
The consecutive addition of ubiquitin moieties generates a polyubiquitin chain.
Proteins tagged with ubiquitin are recognized by a large, barrel-shaped, macromolecular, proteolytic complex called a proteasome, which functions like a garbage disposal.
The proteasome unfolds, deubiquitinates, and cuts the target protein into fragments that are then further degraded to amino acids, which enter the amino acid pool.
The half-life of a protein is influenced by the nature of the N-terminal residue, with proteins that have serine as the N-terminal amino acid being long-lived, and proteins with aspartate as the N-terminal amino acid having a short half-life.
The products of transamination are an alpha keto acid (derived from the original amino acid) and glutamate.
The two most important aminotransferase reactions are catalyzed by alanine aminotransferase (ALT) and aspartate aminotransferase (AST).
The first step in the catabolism of most amino acids is the transfer of their alpha amino group to alpha ketoglutarate.
Glutamate produced by transamination can be oxidatively deaminated, or used as an amino group donor in the synthesis of nonessential amino acids.
The presence of the alpha amino group keeps amino acids safely locked away from oxidative breakdown.
Aminotransferases are named after the specific amino group donor, because the acceptor of the amino group is almost always α-ketoglutarate.
Aspartate aminotransferase (AST) transfers amino groups from glutamate to oxaloacetate, forming aspartate, which is used as a source of nitrogen in the urea cycle.
Removing the α-amino group is essential for producing energy from any amino acid, and is an obligatory step in the catabolism of all amino acids.
Proteins rich in sequences containing proline, glutamate, serine, and threonine (called PEST sequences) are rapidly degraded and, therefore, exhibit short intracellular half-lives.
alpha Ketoglutarate plays a pivotal role in amino acid metabolism by accepting the amino groups from most amino acids, thus becoming glutamate.
Alanine aminotransferase (ALT) is present in many tissues and catalyzes the transfer of the amino group of alanine to α-ketoglutarate, resulting in the formation of pyruvate and glutamate.
All aminotransferases require the coenzyme pyridoxal phosphate (a derivative of vitamin B6), which is covalently linked to the epilson-amino group of a specific lysine residue at the active site of the enzyme.
All amino acids, with the exception of lysine and threonine, participate in transamination at some point in their catabolism.
The transfer of amino groups from one carbon skeleton to another is catalyzed by a family of enzymes called aminotransferases.
Aminotransferases are found in the cytosol and mitochondria of cells throughout the body, especially those of the liver, kidney, intestine, and muscle.
Each aminotransferase is specific for one or, at most, a few amino group donors.
The amino groups of most amino acids are ultimately funneled to glutamate by means of transamination with alpha ketoglutarate.
Glutamate is unique in that it is the only amino acid that undergoes rapid oxidative deamination, a reaction catalyzed by glutamate dehydrogenase.
The glutamine is transported in the blood to the liver where it is cleaved by glutaminase to produce glutamate and free ammonia.
D-Amino acids are present in the diet, and are efficiently metabolized by the kidney and liver.
Oxidative deamination of amino acids involves the liberation of the amino group as free ammonia (NH3) and occurs primarily in the liver and kidney.
D-Amino acid oxidase is an FAD-dependent peroxisomal enzyme that catalyzes the oxidative deamination of these amino acid isomers, producing alpha keto acids, ammonia, and hydrogen peroxide.
Two mechanisms are available in humans for the transport of ammonia from the peripheral tissues to the liver for its ultimate conversion to urea.
The first transport mechanism, found in most tissues, uses glutamine synthetase to combine ammonia (NH3) with glutamate to form glutamine, a nontoxic transport form of ammonia.